Skip to main navigation Skip to search Skip to main content

Metastatic Breast Cancer Patient With Activating HER2 Exon 20 Insertion Mutation With Response to Poziotinib: Case Report of Compassionate Drug Use

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)e7-e11
JournalClinical Breast Cancer
Volume19
Issue number1
DOIs
StatePublished - Feb 2019
Externally publishedYes

Keywords

  • Breast cancer
  • Cancer therapy resistance
  • HER2
  • Tyrosine kinase

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this